CBIZ Report Highlights Rising Costs: Surge in Inpatient and Outpatient Expenses, Popular GLP-1 Drugs like Ozempic Drive Pharmacy Spend Increase
May 20 2025 - 9:00AM
Business Wire
New CBIZ State of Healthcare Report Reveals Cost Increases,
Significant Impact of GLP-1 Drugs on Pharmacy Spend, and Regulatory
Changes Expanding Employee Protections and Accessibility
CBIZ, Inc. (NYSE: CBZ), a leading national professional services
advisor, announced the release of its 2025 State of Healthcare
Report. The report provides a data-driven look at trends affecting
employer-sponsored healthcare and the strategies organizations are
using to stay competitive.
Now, more than ever, employers face increased pressure to
balance affordability with employee wellbeing as healthcare costs
continue to rise. The State of Healthcare Report draws on CBIZ’s
proprietary data from more than 290,000 plan members, delivering
insights into care delivery, cost containment, and regulatory
compliance.
Key insights from the report:
- Healthcare costs continue to rise, with CBIZ data finding that
cost per visit for inpatient, outpatient, and professional care
increased from 2022 to 2024.
- CBIZ data shows that GLP-1s are a significant cost driver in
employers’ pharmacy spend. GLP-1 spend as a percentage of overall
pharmacy spend has increased from 9% in 2022 to 17% in 2024. This
trend is expected to continue as these medications grow in
popularity.
- Ongoing regulatory changes, specifically those occurring at the
state level, are shifting employer-sponsored healthcare. Many of
these regulations expand protections and accessibility for
employees, and employers must continue to monitor relevant
legislation to maintain compliance.
“Healthcare has never been more complex than it is right now,”
said Cole Harris, Business Unit President, National Practice Leader
for Health Innovations. “The report is designed to give employers
real data-driven insights and forward-looking guidance to navigate
our increasingly complex environment.”
The State of Healthcare Report provides a high-level overview of
emerging risks and opportunities, featuring analysis from our
experts on how to proactively tackle these challenges through data,
innovation, and smarter benefits design.
To download the full report, visit 2025 State of Healthcare
Report
About CBIZ
CBIZ, Inc. (NYSE: CBZ) is a leading professional services
advisor to middle market businesses and organizations nationwide.
With unmatched industry knowledge and expertise in accounting, tax,
advisory, benefits, insurance, and technology, CBIZ delivers
forward-thinking insights and actionable solutions to help clients
anticipate what's next and discover new ways to accelerate growth.
CBIZ has more than 10,000 team members across more than 160
locations in 22 major markets coast to coast. For more information,
visit www.cbiz.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250520808811/en/
Media: Amy McGahan, Director of Corporate & Strategic
Communications, amy.mcgahan@cbiz.com
CBIZ (NYSE:CBZ)
Historical Stock Chart
From Jun 2025 to Jul 2025
CBIZ (NYSE:CBZ)
Historical Stock Chart
From Jul 2024 to Jul 2025